77 drugs from multiple manufacturers are required to reduce the price, otherwise the network will be removed

On October 17, Guangxi Zhuang Autonomous Region's centralized purchase network of drugs and devices released the notice on urging the declaration and price reduction of imported drugs and anticancer drugs Since 2015, Guangxi Zhuang Autonomous Region ', There are still some imported drugs and anti-cancer drugs whose prices haven't been lowered in place In order to further reduce the tax and price of imported drugs and anticancer drugs, we hereby notify the relevant matters concerning the price reduction of imported drugs and anticancer drugs 1、 Range of varieties: in 2015, the drugs from medical and health institutions in Guangxi Zhuang Autonomous Region were shortlisted / online, involving the imported drugs and anti-cancer drugs without price reduction after tax reduction 2、 The materials shall be submitted to the manufacturer to apply for price reduction according to the notice on receiving the application materials for adjusting the price of imported drugs and anti-cancer drugs shortlisted for centralized purchase of drugs by medical and health institutions in Guangxi Zhuang Autonomous Region in 2015 (link address: http://gxyxcg.gxzf.gov.cn / search / show779 HTML) on July 24, 2018 For varieties not affected by the tax reduction policy, please provide relevant supporting materials 3、 The materials can be submitted by the relevant drug manufacturers on the date of price reduction The deadline is October 31, 2019, and the overdue materials will not be accepted As of 17:00 p.m on October 31, 2019, if no materials have been submitted, the varieties that have not applied for price reduction will be submitted to the Medical Security Bureau of Guangxi Zhuang Autonomous Region to decide to stop the online trading qualification This time, there are 343 items of different specifications in the list, including 77 different drugs, most of which are not depreciated without justifiable reasons And basically the price of each drug manufacturer is clearly marked Statement: this opinion only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.